Unlock Your Trading Potential: Discover the Latest FX Option Expiries for 17 May at 10am New York Cut!

Unlock Your Trading Potential: Discover the Latest FX Option Expiries for 17 May at 10am New York Cut! Description: EUR/USD- 1.0795-10 (€751m)- 1.0825-35 (€556m)- 1.0915-20 (€619m) USD/JPY- 134.50 ($2.1bn)- 135.50 ($1.3bn)- 136.00-10 ($1.3bn)- 136.80 ($806m)- 137.00 ($503m) USD/CAD- 1.3400 ($1.2bn)- 1.3450 ($1.3bn) EUR/JPY- 141.00 (€1.0bn) There are a couple of big ones to take note…

Read More

Introducing Ochre Bio’s New Chairperson: Eliot Forster, Ph.D. Joins the Board of Directors

Ochre Bio Appoints Dr. Eliot Forster as Chairperson of the Board of Directors OCHRE, England – Ochre Bio, a leader in chronic liver disease medication development, proudly announces the selection of Dr. Eliot Forster as Chairman of the Board of Directors. Dr. Eliot Forster: A Leader in the Pharmaceutical and Biotechnology Industries Dr. Forster brings…

Read More

Breaking News: Infinera Corporation Buys Back $83.9M in Convertible Senior Notes with Proceeds from Reopening of 2028 Notes!

Breaking News: Infinera Corporation Buys Back $83.9M in Convertible Senior Notes with Proceeds from Reopening of 2028 Notes! Description: Transactions further strengthen Infinera balance sheet while keeping average debt coupon expense at less than 3.5% across capital structure SAN JOSE, Calif., May 16, 2023 (GLOBE NEWSWIRE) — Infinera Corporation (NASDAQ: INFN) announced today that, to…

Read More

Breaking News: Everest Medicines Successfully Completes Patient Enrollment for Etrasimod Phase 3 Clinical Trial in Asia

Exciting News in the Biopharmaceutical Field May 17, 2023 SHANGHAI, May 17, 2023 /PRNewswire/ — Everest Medicines (HKEX 1952.HK, “Everest”, or the “Company”), a biopharmaceutical company focused on the development, manufacturing and commercialization of innovative medicines and vaccines, announced today the completion of patient enrollment in a multi-center Phase 3 clinical trial of etrasimod in…

Read More

Attention Investors: Don’t Miss Out on Compensation! Skilled Counsel Urges Teleperformance SE Shareholders to Act Now in Securities Class Action Lawsuit – Here’s Why

Welcome to Rosen Law Firm: Your Investor Rights Law Firm Important Deadline Alert for Teleperformance SE Investors New York, May 16, 2023 (GLOBE NEWSWIRE) – Rosen Law Firm Rosen Law Firm, a global investor rights law firm, is here to remind purchasers of the American Depositary Receipts (“ADRs”) of Teleperformance SE (OTC: TLPFY) about an…

Read More

Intermap Celebrates 50% Growth in Subscription Renewal with California State: A Testament to Our Commitment and Quality Service

Supporting California’s Strategic Data Infrastructure and Operations with High-Resolution Elevation Models DENVER, May 16, 2023 (GLOBE NEWSWIRE) — Intermap Technologies (TSX: IMP; OTCQB: ITMSF) (“Intermap” or the “Company”), a global leader in 3D geospatial products and intelligence solutions, today announced a two-year renewal of its elevation data subscription contract with the State of California Intermap…

Read More

Ugandans and Polish Visa Applicants Left Stranded After Kampala Embassy Offices Disappear with No Trace: The Visa Scam You Need to Know About!

VISA SCAM? Ugandan Polish Visa Applicants Stranded After Kampala Embassy Offices Disappear With No Trace What Really Happened? Hundreds of Ugandans have been left in distress after discovering that the Polish Embassy offices in Nairobi have disappeared with no trace, along with their hard-earned money. It all started when over 200 Ugandans who had applied…

Read More